MRI/Ultrasound Fusion Guided Prostate Cryotherapy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age55+
SponsorUrological Research Network, LLC
About this trial
Registration of Prostate Cancer patients undergoing Prostate Cryotherapy guided by Mutiparametric-MRI (MP-MRI) highlighting biopsy confirmed regions. The primary outcome measure is 5 year oncological control. Secondary aim is lack of progression beyond the prostate gland. The aim of intervention is to eradicate prostate cancer disease in the treated area while imposing no or minimal deleterious effects in quality of life.
Eligibility criteria
Qualifiers
Men between 55 and 65 years of age with a clinical diagnosis of prostate cancer with Low or Intermediate risk prostate cancer, and <50% positive core rate by prostate lobe
Men older than 65 years of age with clinical diagnosis of prostate cancer <50% positive core rate by prostate lobe
Absence of extra-capsular extension
Absence of seminal vesicle invasion
Disqualifiers
Prior treatment of prostate cancer in the form of surgery.
Performance status greater than 0 based on ECOG criteria
Mental status impairment
Trial design
Treatments tested in this trial
- FUSE IMAGE MRI GUIDED PROSTATE CRYOTHERAPY
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov